Clinical trial
A Phase II Trial of Celecoxib in Patients With IPMN
NCT00198081 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Trial of Celecoxib in Patients With IPMN
- Lead sponsor
- Indiana University
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- September 30, 2005
- Completion date
- April 30, 2012
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pancreas neoplasms